E Fund Management (HK)’s Royalty Pharma RPRX Stock Holding History

E Fund Management (HK)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.9K	Buy	427 +110	+35%	+$5.72K	0.01%	278
2026 Q1	$15.2K	Buy	+317	New	+$13.9K	0.01%	246

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

E Fund Management (HK)'s RPRX Position: Q2 2026 in Review

E Fund Management (HK) increased its Royalty Pharma (RPRX) stake by 35% in Q2 2026, buying an estimated $5.72K and bringing the position to 427 shares worth $23.9K. The position accounts for 0.01% of the portfolio, ranked #278.

E Fund Management (HK) first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

E Fund Management (HK) held 427 shares of Royalty Pharma worth $23.9K as of Q2 2026.
E Fund Management (HK) bought 110 Royalty Pharma shares in Q2 2026, an estimated $5.72K.
Royalty Pharma made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #278 holding.
E Fund Management (HK) first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.